Griffin Asset Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Griffin Asset Management, Inc.

$879 Million
Q3 2024

A detailed history of Griffin Asset Management, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Griffin Asset Management, Inc. holds 8,713 shares of VRTX stock, worth $4.05 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

8,713

Previous 8,698 0.17%

Holding current value

$4.05 Million

Previous $4.08 Million 0.59%

% of portfolio

0.46%

Previous 0.48%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$460.0 - $505.78 $6,900 - $7,586	15 Added 0.17%	8,713 $4.05 Million
Q2 2024 Jul 23, 2024	SELL	$392.81 - $485.53 $41,245 - $50,980	-105 Reduced 1.19%	8,698 $4.08 Million
Q1 2024 Apr 17, 2024	SELL	$407.69 - $446.08 $64,007 - $70,034	-157 Reduced 1.75%	8,803 $3.68 Million
Q4 2023 Jan 19, 2024	BUY	$343.0 - $410.68 $45,276 - $54,209	132 Added 1.5%	8,960 $3.65 Million
Q3 2023 Oct 19, 2023	BUY	$338.18 - $362.46 $13,527 - $14,498	40 Added 0.46%	8,828 $3.07 Million
Q1 2023 May 09, 2023	SELL	$283.23 - $323.1 $117,823 - $134,409	-416 Reduced 4.52%	8,788 $2.77 Million
Q4 2022 Jan 20, 2023	SELL	$285.76 - $321.48 $103,730 - $116,697	-363 Reduced 3.79%	9,204 $0
Q3 2022 Oct 19, 2022	SELL	$273.83 - $305.53 $15,060 - $16,804	-55 Reduced 0.57%	9,567 $2.77 Million
Q2 2022 Jul 19, 2022	SELL	$234.96 - $292.55 $1,879 - $2,340	-8 Reduced 0.08%	9,622 $2.71 Million
Q1 2022 Apr 12, 2022	BUY	$221.42 - $260.97 $431,990 - $509,152	1,951 Added 25.41%	9,630 $2.51 Million
Q4 2021 Jan 28, 2022	BUY	$177.01 - $223.45 $142,493 - $179,877	805 Added 11.71%	7,679 $1.69 Million
Q2 2021 Jul 28, 2021	BUY	$187.49 - $221.1 $277,485 - $327,228	1,480 Added 27.44%	6,874 $1.39 Million
Q1 2021 May 04, 2021	BUY	$207.02 - $241.31 $341,583 - $398,161	1,650 Added 44.07%	5,394 $1.16 Million
Q4 2020 Jan 27, 2021	BUY	$207.01 - $276.09 $26,704 - $35,615	129 Added 3.57%	3,744 $885,000
Q3 2020 Nov 12, 2020	SELL	$255.65 - $303.1 $42,182 - $50,011	-165 Reduced 4.37%	3,615 $984,000
Q2 2020 Aug 18, 2020	SELL	$225.48 - $295.8 $6,764 - $8,874	-30 Reduced 0.79%	3,780 $1.1 Million
Q1 2020 May 18, 2020	BUY	$199.77 - $247.81 $761,123 - $944,156	3,810 New	3,810 $907,000
Q3 2019 Nov 05, 2019	SELL	$166.23 - $187.09 $101,898 - $114,686	-613 Closed	0 $0
Q2 2019 Aug 19, 2019	BUY	$164.61 - $190.37 $100,905 - $116,696	613 New	613 $112,000

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Griffin Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Griffin Asset Management, Inc. with notifications on news.

Account

Griffin Asset Management, Inc. Vertex Pharmaceuticals Inc Transaction History